The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer: A systematic review

M. Timmermans; O. van der Hel; G. S. Sonke; K. K. Van de Vijver; M. A. van der Aa; R. F. Kruitwagen

doi:10.1016/j.ygyno.2019.02.019

The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer: A systematic review

M. Timmermans^*, O. van der Hel, G. S. Sonke, K. K. Van de Vijver, M. A. van der Aa, R. F. Kruitwagen

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	445-451
Number of pages	7
Journal	Gynecologic Oncology
Volume	153
Issue number	2
DOIs	https://doi.org/10.1016/j.ygyno.2019.02.019
Publication status	Published - May 2019

Keywords

Neoadjuvant chemotherapy
Interval cytoreductive surgery
Outcome of surgery
Overall survival
ADVANCED-STAGE OVARIAN
PRIMARY CYTOREDUCTIVE SURGERY
INTERVAL DEBULKING SURGERY
GYNECOLOGIC ONCOLOGISTS
SURGICAL CYTOREDUCTION
AGGRESSIVE SURGERY
PERITONEAL CANCER
IV OVARIAN
SURVIVAL
CARCINOMA

Access to Document

10.1016/j.ygyno.2019.02.019

Cite this

Timmermans, M., van der Hel, O., Sonke, G. S., Van de Vijver, K. K., van der Aa, M. A., & Kruitwagen, R. F. (2019). The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer: A systematic review. Gynecologic Oncology, 153(2), 445-451. https://doi.org/10.1016/j.ygyno.2019.02.019

@article{ce0429218f8341d3adb1389e4157399c,

title = "The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer: A systematic review",

keywords = "Neoadjuvant chemotherapy, Interval cytoreductive surgery, Outcome of surgery, Overall survival, ADVANCED-STAGE OVARIAN, PRIMARY CYTOREDUCTIVE SURGERY, INTERVAL DEBULKING SURGERY, GYNECOLOGIC ONCOLOGISTS, SURGICAL CYTOREDUCTION, AGGRESSIVE SURGERY, PERITONEAL CANCER, IV OVARIAN, SURVIVAL, CARCINOMA",

author = "M. Timmermans and {van der Hel}, O. and Sonke, {G. S.} and {Van de Vijver}, {K. K.} and {van der Aa}, {M. A.} and Kruitwagen, {R. F.}",

year = "2019",

month = may,

doi = "10.1016/j.ygyno.2019.02.019",

language = "English",

volume = "153",

pages = "445--451",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Elsevier Science",

number = "2",

}

The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer : A systematic review. / Timmermans, M.; van der Hel, O.; Sonke, G. S.; Van de Vijver, K. K.; van der Aa, M. A.; Kruitwagen, R. F.

In: Gynecologic Oncology, Vol. 153, No. 2, 05.2019, p. 445-451.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer

T2 - A systematic review

AU - Timmermans, M.

AU - van der Hel, O.

AU - Sonke, G. S.

AU - Van de Vijver, K. K.

AU - van der Aa, M. A.

AU - Kruitwagen, R. F.

PY - 2019/5

Y1 - 2019/5

KW - Neoadjuvant chemotherapy

KW - Interval cytoreductive surgery

KW - Outcome of surgery

KW - Overall survival

KW - ADVANCED-STAGE OVARIAN

KW - PRIMARY CYTOREDUCTIVE SURGERY

KW - INTERVAL DEBULKING SURGERY

KW - GYNECOLOGIC ONCOLOGISTS

KW - SURGICAL CYTOREDUCTION

KW - AGGRESSIVE SURGERY

KW - PERITONEAL CANCER

KW - IV OVARIAN

KW - SURVIVAL

KW - CARCINOMA

U2 - 10.1016/j.ygyno.2019.02.019

DO - 10.1016/j.ygyno.2019.02.019

M3 - Review article

VL - 153

SP - 445

EP - 451

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -